Using cancer's strength to fight against it
- Details
- Category: Research
By studying mutations in malignant T cells that cause lymphoma, they zeroed in on one that imparted exceptional potency to engineered T cells. Inserting a gene encoding this unique mutation into normal human T cells made them more than 100 times more potent at killing cancer cells without any signs of becoming toxic.
Chapman scientists code ChatGPT to design new medicine
- Details
- Category: Research
Today, scientists use advanced technology to design new synthetic drug compounds with the right properties and characteristics, also known as "de novo drug design." However, current methods can be labor-, time-, and cost-intensive.
MSU researchers find early, promising glioblastoma treatment
- Details
- Category: Research
A team of Michigan State University scientists has unveiled a potential game-changer in the fight against glioblastoma, the most common and currently incurable form of brain cancer.
Cheating death: How cancer cells escape
- Details
- Category: Research
Nanotechnology-based CRISPR/Cas9 delivery system for genome editing in cancer treatment
- Details
- Category: Research
Up to three daily servings of kimchi may lower men's obesity risk
- Details
- Category: Research
Kimchi is made by salting and fermenting vegetables with various flavourings and seasonings, such as onion, garlic, and fish sauce.
New technology makes cancer easier for immune system to find and destroy
- Details
- Category: Research
Major histocompatibility complex (MHC) class I molecules are an immune complex present on the surface of all cells in humans. MHC class I molecules are a prerequisite for the immune system to recognize and eliminate cancer.
More Pharma News ...
- 'Cancer-cooling' protein puts bowel cancer on ice
- Autonomous synthesis robot uses AI to speed up chemical discovery
- Could two drugs be better than one for treating prostate cancer?
- New medicine can create a new life for diabetes patients - without needles
- Complement system causes cell damage in Long COVID
- Molecular 'super-glue' shows promise of cancer drug discovery platform
- Accelerating how new drugs are made with machine learning